Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2638 SEK | +0.61% | +4.68% | -43.63% |
Aug. 20 | Starbreeze AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
Jul. 02 | Starbreeze AB Provides Update on Operation Medic Bag | CI |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 280M | 118M | 126M | 128M | 634M | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 280M | 118M | 126M | 128M | 634M | |||||
Cost of Goods Sold, Total | 341M | 31.07M | 56.3M | 60.53M | 309M | |||||
Gross Profit | -61.21M | 86.93M | 69.39M | 67.08M | 324M | |||||
Selling General & Admin Expenses, Total | 122M | 77.89M | 64.1M | 79.87M | 126M | |||||
Depreciation & Amortization - (IS) | - | - | - | - | - | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | - | |||||
Other Operating Expenses | -19.22M | -1.1M | -3.12M | -15.4M | -13.71M | |||||
Other Operating Expenses, Total | 102M | 76.79M | 60.99M | 64.47M | 113M | |||||
Operating Income | -164M | 10.14M | 8.4M | 2.61M | 212M | |||||
Interest Expense, Total | -30.87M | -48.96M | -51.58M | -59.25M | -359K | |||||
Interest And Investment Income | - | - | - | - | 3.1M | |||||
Net Interest Expenses | -30.87M | -48.96M | -51.58M | -59.25M | 2.74M | |||||
Income (Loss) On Equity Invest. | -1.46M | -2.11M | 50K | 168K | -64K | |||||
Currency Exchange Gains (Loss) | - | -5.62M | 6.55M | 4.14M | -21.41M | |||||
Other Non Operating Income (Expenses) | 167K | 658K | 25K | -2.07M | 14.68M | |||||
EBT, Excl. Unusual Items | -196M | -45.89M | -36.55M | -54.4M | 208M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -30.6M | 6.36M | -68.67M | - | - | |||||
Asset Writedown | -320M | - | - | - | - | |||||
Other Unusual Items | 94.29M | -90.93M | - | - | - | |||||
EBT, Incl. Unusual Items | -452M | -130M | -105M | -54.4M | 208M | |||||
Income Tax Expense | -51.32M | -193K | -1.76M | 5.4M | 24K | |||||
Earnings From Continuing Operations | -401M | -130M | -103M | -59.81M | 208M | |||||
Net Income to Company | -401M | -130M | -103M | -59.81M | 208M | |||||
Minority Interest | -150K | - | - | - | - | |||||
Net Income - (IS) | -401M | -130M | -103M | -59.81M | 208M | |||||
Net Income to Common Incl Extra Items | -401M | -130M | -103M | -59.81M | 208M | |||||
Net Income to Common Excl. Extra Items | -401M | -130M | -103M | -59.81M | 208M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -1.22 | -0.28 | -0.14 | -0.08 | 0.19 | |||||
Basic EPS - Continuing Operations | -1.22 | -0.28 | -0.14 | -0.08 | 0.19 | |||||
Basic Weighted Average Shares Outstanding | 328M | 470M | 725M | 725M | 1.1B | |||||
Net EPS - Diluted | -1.22 | -0.28 | -0.14 | -0.08 | 0.19 | |||||
Diluted EPS - Continuing Operations | -1.22 | -0.28 | -0.14 | -0.08 | 0.19 | |||||
Diluted Weighted Average Shares Outstanding | 328M | 470M | 725M | 725M | 1.1B | |||||
Normalized Basic EPS | -0.37 | -0.06 | -0.03 | -0.05 | 0.12 | |||||
Normalized Diluted EPS | -0.37 | -0.06 | -0.03 | -0.05 | 0.12 | |||||
Supplemental Items | ||||||||||
EBITDA | -130M | 32.02M | 14.02M | 4M | 213M | |||||
EBITA | -160M | 10.22M | 8.4M | 2.61M | 212M | |||||
EBIT | -164M | 10.14M | 8.4M | 2.61M | 212M | |||||
EBITDAR | -101M | 41.16M | 15.44M | 10.69M | 221M | |||||
Total Revenues (As Reported) | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 11.34 | 0.15 | 1.67 | -9.94 | 0.01 | |||||
Total Current Taxes | 64K | 1.42M | 3.87M | 1.3M | 34K | |||||
Total Deferred Taxes | -51.39M | -1.61M | -5.63M | 4.1M | -10K | |||||
Normalized Net Income | -123M | -28.68M | -22.85M | -34M | 130M | |||||
Interest on Long-Term Debt | 19.96M | 24.28M | 29.1M | 33.6M | 359K | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 12.05M | 8.46M | 12.95M | 15.8M | 46.82M | |||||
General and Administrative Expenses | 110M | 69.43M | 51.16M | 64.07M | 79.41M | |||||
Research And Development Expense From Footnotes | 186M | 4.47M | 10.58M | 16.5M | 189M | |||||
Net Rental Expense, Total | 29.38M | 9.14M | 1.42M | 6.69M | 8.42M | |||||
Imputed Operating Lease Interest Expense | 18.71M | 9.18M | 1.41M | 6.17M | 81.39K | |||||
Imputed Operating Lease Depreciation | 10.67M | -39.87K | 12.71K | 518K | 8.34M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 27K | - | - | - | - | |||||
Total Stock-Based Compensation | 27K | - | - | - | - |